Recent Articles

• ImCheck Therapeutics Showcases Promising AML Therapy Results
• Legend Biotech Reveals Significant Updates in Cancer Treatment
• ROHM Introduces Next-Gen Compact NIR LEDs for Advanced Applications
• Cullinan Therapeutics and Partners Showcase Breakthrough Cancer Trial Findings
• Biodesix Unveils Promising Data on VeriStrat Test for NSCLC
• Acceleware Ltd. Achieves Significant Progress in Q1 2025
• Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting
• Petrus Resources Shares Success of Annual Meeting Outcomes
• Exciting Phase 2 Results from Actuate's Elraglusib in Cancer Treatment
• Candel Therapeutics Advances Localized Prostate Cancer Treatment
• Adagene Showcases Promising Results for ADG126 in Cancer Trials
• Banco Comercial Português Highlights Key AGM Resolutions
• Wheaton Precious Metals Unveils 2024 Reports on Sustainability and Climate
• Novita Reports Encouraging Phase 2 Trial Results for NP-G2-044
• Accent Therapeutics Showcases Innovative Cancer Treatment Advances
• Cizzle Bio's CIZ1B Test Offers Significant Medicare Savings
• Ontario International Airport Sees Record Passenger Growth
• Foresight Diagnostics Validates CLARITY MRD Assay for DLBCL
• XTANDI™ Breakthrough: Prostate Cancer Patients See 30% Survival Increase
• Servier Showcases Commitment to IDH-Mutated Cancer Research
• West Fraser Timber's Commitment to Sustainability in 2024
• Boehringer Ingelheim's Ambitious Plan for Future Cancer Innovations
• Taiho Oncology Unveils Groundbreaking Cancer Therapy Data
• Eli Lilly Unveils Research Presentations for ASCO 2025 Meeting
• COOFANDY Celebrates a Decade of Excellence with Major Awards
• Unlocking Earning Potential: FioBit's AI Mining Revolution 2025
• Unlock Passive Income with PAIRMiner's Cutting-Edge Mining
• THOR Industries Prepares for Upcoming Q3 2025 Earnings Call
• Clear Blue Technologies Plans Corporate Update and Q1 2025 Report
• Bicara Therapeutics Shares Key Data on Ficerafusp Alfa Therapy
• Northview Residential REIT Declares Latest Distribution for Investors
• Zymeworks Showcases Cancer Treatments at Major Medical Events
• VCI Global's Equity Agreement Revamped for Strategic Growth
• Innovative Treatment Combines Linvoseltamab with Proteasome Inhibitors
• Stephen Brannan Joins Serina Therapeutics Board for Growth
• Onconetix Inc. Faces Delisting Notice from Nasdaq Amid Compliance Issues
• Cal Redwood Acquisition Corp. Successfully Prices $200 Million Offering
• Gemspring Capital Expands Portfolio with Goodyear Chemical Acquisition
• Life Time Eagle: A New Era for Health and Wellness In Idaho
• RNR Tire Express Celebrates Community Impact and Awards
• Southwest Airlines to Discuss Strategic Plans at Major Conference
• Transforming Global Payments: How TransFi's BizPay Innovates Business Transactions
• First Capital, Inc. Declares New Dividend for Shareholders
• Biodexa Pharmaceuticals' Upcoming General Meeting Announced
• Interpublic Board Approves Quarterly Dividend Payment Announcement
• Bio-Path Holdings Discusses Key Developments in Upcoming Call
• Crown LNG Holdings Limited Updates on NASDAQ Compliance Status
• Red River Bancshares, Inc. Engages in Significant Stock Buyback
• Medallion Bank Successfully Completes Series G Stock Offering
• Athene Holding Ltd. Announces Dividend for Preferred Shares